MENU
+Compare
AXSM
Stock ticker: NASDAQ
AS OF
Aug 28 closing price
Price
$121.75
Change
-$0.11 (-0.09%)
Capitalization
6.08B

AXSM Axsome Therapeutics Forecast, Technical & Fundamental Analysis

Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company... Show more

AXSM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for AXSM with price predictions
Aug 28, 2025

Momentum Indicator for AXSM turns positive, indicating new upward trend

AXSM saw its Momentum Indicator move above the 0 level on August 11, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 70 similar instances where the indicator turned positive. In of the 70 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for AXSM just turned positive on August 11, 2025. Looking at past instances where AXSM's MACD turned positive, the stock continued to rise in of 47 cases over the following month. The odds of a continued upward trend are .

AXSM moved above its 50-day moving average on August 13, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for AXSM crossed bullishly above the 50-day moving average on August 18, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where AXSM advanced for three days, in of 288 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 11 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AXSM declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

AXSM broke above its upper Bollinger Band on August 20, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for AXSM entered a downward trend on August 13, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. AXSM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock slightly better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (83.333) is normal, around the industry mean (19.700). P/E Ratio (0.000) is within average values for comparable stocks, (54.040). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.655). Dividend Yield (0.000) settles around the average of (0.043) among similar stocks. P/S Ratio (11.990) is also within normal values, averaging (303.721).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

View a ticker or compare two or three
AXSM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

AXSM is expected to report earnings to fall 14.57% to -82 cents per share on November 10

Axsome Therapeutics AXSM Stock Earnings Reports
Q3'25
Est.
$-0.83
Q2'25
Beat
by $0.09
Q1'25
Beat
by $0.08
Q4'24
Missed
by $0.58
Q3'24
Beat
by $0.04
The last earnings report on August 04 showed earnings per share of -97 cents, beating the estimate of -105 cents. With 369.67K shares outstanding, the current market capitalization sits at 6.08B.
A.I. Advisor
published General Information

General Information

a provider of biopharmaceutical services for pain and other nervous system

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
One World Trade Center
Phone
+1 212 332-3241
Employees
545
Web
https://www.axsome.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CSPAX73.780.20
+0.27%
American Funds SMALLCAP World 529A
ETNMX14.900.02
+0.16%
Eventide Balanced Fund Class N
SCJIX8.16N/A
N/A
Steward Covered Call Income I
JSEQX55.31N/A
N/A
JPMorgan Small Cap Equity R4
MEMSX8.95N/A
N/A
Mercer Emerging Markets Equity I

AXSM and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, AXSM has been loosely correlated with CRNX. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if AXSM jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AXSM
1D Price
Change %
AXSM100%
-0.09%
CRNX - AXSM
40%
Loosely correlated
+0.82%
ALNY - AXSM
37%
Loosely correlated
-0.41%
XENE - AXSM
36%
Loosely correlated
-0.69%
IONS - AXSM
36%
Loosely correlated
-0.30%
VANI - AXSM
36%
Loosely correlated
-3.28%
More